CLAVASEPTIN 250 MG PALATABLE TABLETS FOR DOGS

国家: 澳大利亚

语言: 英文

来源: APVMA (Australian Pesticides and Veterinary Medicines Authority)

有效成分:

AMOXYCILLIN AS AMOXYCILLIN TRIHYDRATE; CLAVULANIC ACID AS POTASSIUM CLAVULANATE

可用日期:

VETOQUINOL AUSTRALIA PTY LTD

药物剂型:

ORAL TABLET

组成:

AMOXYCILLIN AS AMOXYCILLIN TRIHYDRATE ANTIBIOTIC Active 200.0 mg; CLAVULANIC ACID AS POTASSIUM CLAVULANATE ANTIBIOTIC Active 50.0 mg

每包单位数:

10 Tablets; 100 Tablets; 1000 Tablets; 120 Tablets; 150 Tablets; 20 Tablets; 200 Tablets; 250 Tablets; 300 Tablets; 400 Tablets; 50 Tablets; 500 Tablets; 600 Tablets; 750 Tablets

类:

VM - Veterinary Medicine

治疗领域:

ANTIBIOTIC & RELATED

產品總結:

Poison schedule: 4; Withholding period: ; Host/pest details: DOG: [BORDETELLA BRONCHISEPTICA, CORYNEBACTERIUM SPP., ESCHERICHIA COLI (E. COLI), KLEBSIELLA SPP., PASTEURELLA SPP., PROTEUS MIRABILIS, SALMONELLA, STAPHYLOCOCCUS SPP., STREPTOCOCCUS SPP.]

授权状态:

Registered

授权日期:

2023-07-01

资料单张

Product Name:
APVMA Approval No:
CLAVASEPTIN 250 MG PALATABLE TABLETS FOR DOGS
88162/120467
Label Name:
CLAVASEPTIN 250 MG PALATABLE TABLETS FOR DOGS
Signal Headings:
PRESCRIPTION ANIMAL REMEDY
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
Constituent
Statements:
200 mg AMOXICILLIN (as Amoxicillin trihydrate)
50 mg CLAVULANIC ACID (as Potassium Clavulanate)
Each CLAVASEPTIN 250 mg PALATABLE TABLET contains 200 mg of
AMOXICILLIN (as
Amoxicillin trihydrate) and 50 mg of CLAVULANIC ACID (as Potassium
clavulanate).
Claims:
For the treatment of bacterial infections sensitive to Clavulanic Acid
and Amoxicillin in dogs.
Clinically CLAVASEPTIN has been shown to be effective in treating a
wide range of
diseases of dogs including:
• Skin diseases (including deep and superficial pyodermas)
• Urinary tract infection
• Respiratory disease (involving upper and lower respiratory tract)
• Enteritis
CLAVASEPTIN Palatable Tablets have a notably broad spectrum of
bactericidal activity
against bacteria commonly found in dogs and are indicated for the oral
treatment of
bacterial infections caused by susceptible organisms.
Resistance may develop to any antimicrobial.
In vitro CLAVASEPTIN is active against a wide range of clinically
important bacteria
including:
Gram-positive
Staphylococcus spp. (including ß-lactamase producing strains)
Corynebacterium spp.
Streptococcus spp.
Gram-negative
Escherichia coli (including ß-lactamase producing strains)
Salmonella spp. (including ß-lactamase producing strains)
Bordetella bronchiseptica; Pasteurella; Proteus mirabilis and other
sensitive strains;
Klebsiella. RLP APPROVED
CLAVASEPTIN is not indicated for cases involving Pseudomonas spp.
Use as directed by prescribing veterinarian.
Net Contents:
10 [20, 50 100, 120, 150, 200, 250, 300, 400, 500, 600, 750, 1000]
Tablets
Directions for Use:
Restraints:
Contraindications:
This product is contraindicated for use in animals that are
hypersensitive to or have a
history of allergic reactions to penicillins.
This product is contrai